Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion.
This study investigated the serum vascular endothelial growth factor (VEGF) levels in children with community-acquired pneumonia. Serum VEGF levels were measured in patients with pneumonia (n=29) and in control subjects (n=27) by a sandwich enzyme-linked immunosorbent assay. The pneumonia group was classified into bronchopneumonia with pleural effusion (n=1), bronchopneumonia without pleural effusion (n=15), lobar pneumonia with pleural effusion (n=4), and lobar pneumonia without pleural effusion (n=9) groups based on the findings of chest radiographs. We also measured serum IL-6 levels and the other acute inflammatory parameters. Serum levels of VEGF in children with pneumonia were significantly higher than those in control subjects (p<0.01). Children with lobar pneumonia with or without effusion showed significantly higher levels of serum VEGF than children with bronchopneumonia. For lobar pneumonia, children with pleural effusion showed higher levels of VEGF than those without pleural effusion. Children with a positive urinary S. pneumonia antigen test also showed higher levels of VEGF than those with a negative result. Serum IL-6 levels did not show significant differences between children with pneumonia and control subjects. Serum levels of VEGF showed a positive correlation with the erythrocyte sedimentation rate in the children with pneumonia. In conclusion, VEGF may be one of the key mediators that lead to lobar pneumonia and parapneumonic effusion.
Choi
Seong Hwan
SH
Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Jongro-gu, Seoul, Korea.
Park
Eun Young
EY
Jung
Hye Lim
HL
Shim
Jae Won
JW
Kim
Deok Soo
DS
Park
Moon Soo
MS
Shim
Jung Yeon
JY
D000293:Adolescent; D000907:Antibodies, Bacterial / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D017714:Community-Acquired Infections / Q000097:blood / Q000382:microbiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007223:Infant; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D009177:Mycoplasma pneumoniae / Q000254:growth & development / Q000276:immunology; D010996:Pleural Effusion / Q000097:blood* / Q000150:complications / Q000382:microbiology; D018410:Pneumonia, Bacterial / Q000097:blood* / Q000150:complications / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000254:growth & development / Q000276:immunology; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D015850:Interleukin-6; D042461:Vascular Endothelial Growth Factor A